Results
|
|
1.
|
Is There a Role for Triple Therapy After ACS?. [Review] MedStar authors:
Year: 2022
Citation: - Current Cardiology Reports. 24(3):191-200, 2022 Mar.
Institution: - MedStar Washington Hospital Center
Department: - Advanced Cardiac Catheterization Research Fellowship
Medline publication type:
All authors: - Alkhouli M, Bailey S, Bhogal S, Haddad E, Mamas M, Paul TK, White CJ
|
|
|
2.
|
Dual antithrombotic plus adjunctive antiinflammatory therapy to improve cardiovascular outcome in atrial fibrillation patients with concurrent acute coronary syndrome: A triple-pathway strategy. MedStar authors:
Year: 2018
Citation: - Medical Hypotheses. 114:40-44, 2018 May
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Balouch MA, Chi G, Jafarizade M, Jamil A, Jamil U, Kalayci A, Karimi Z, Kumar S, Marszalek J, Pahlavani S, Radulovic M, Shaukat H
|
|
|
3.
|
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III). MedStar authors:
- Dvir, Danny
- Swymelar, Stacy
- Torguson, Rebecca
- Waksman, Ron
- Xue, Zhenyi
Year: 2013
Citation: - Journal of Interventional Cardiology. 26(2):107-13, 2013 Apr.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Bertrand O, Driesman M, Dvir D, Gruberg L, Mehta S, Rossi J, Swymelar S, Torguson R, Waksman R, Xue Z
|
